Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
about
Role of Nuclear Receptors in Central Nervous System Development and Associated DiseasesAnalysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems.Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer.Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesisVariable expression of nuclear receptor coactivator 4 (NcoA4) during mouse embryonic developmentDynamic distribution of nuclear coactivator 4 during mitosis: association with mitotic apparatus and midbodies.The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expressionAndrogen receptor signaling in prostate cancer development and progression.Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists.Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer.Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Degradation and beyond: control of androgen receptor activity by the proteasome system.New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.Targeted therapy of cancer: new roles for pathologists--prostate cancer.Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Androgen receptor coactivators that inhibit prostate cancer growthEngineered repressors are potent inhibitors of androgen receptor activity.Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation.Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells.Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells.Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancerStearoyl-CoA desaturase induces lipogenic gene expression in prostate cancer cells and inhibits ceramide-induced cell death
P2860
Q27025212-7442D7FC-A350-44A7-95E4-3499150771C3Q33529070-8F5DC9AD-58E0-4FD5-B2DC-F07033FEB9F2Q33745234-477B2420-DC92-4CCE-8C70-B7201C79DF1EQ33750087-762344AD-8214-4C33-9F0B-59F793FEF487Q33928819-227E81BE-AAA5-4DBD-97C9-BA3A970A3C3DQ33981483-8A8CC769-F78A-43AC-9127-DCF28EA33B45Q34473887-A0DF63E4-0BEC-4AE9-B7D1-FC211D4DBBA2Q35003769-887BC4A5-8710-4E21-9A75-F552EA81E1DBQ35183663-11A22516-4599-4AC4-ABB9-F4C1D1C69BA0Q35762232-B316ED88-56D2-411E-8B38-F8B5C6BE1C37Q36344198-14ED0B9B-7BB2-4D96-9C1B-B73810834518Q36357367-F763DF83-2676-417E-9964-DD8016A8EBFCQ36382025-8C2F3099-DAF9-4A3D-8164-48E35012FF46Q36496051-D878757F-2177-4B13-9962-69B47812306EQ36539137-945362A2-1772-4D6D-BB3E-B237BEDE3901Q36582853-D255EEDD-0A14-4E0B-B49F-24A69A6EA9ECQ37147772-CA6B6C52-3934-47D0-96E3-C2277288E236Q37601718-4D9ED127-5BF5-4180-B7A3-8AC6481C44EEQ37728852-8102A6E3-5963-4228-A65F-7582CC5CBCC0Q37965553-1F68871A-65F1-43F1-8F36-68AF733EECA3Q38265571-AD450255-2548-4711-82AE-F901BC4B3487Q39012681-0F7B3D76-4B6D-4358-94CC-3989C2DFDB8AQ39079725-B0554553-B382-456E-B18A-FD2C77F8DC82Q39945610-354E9AEB-4F0E-44F0-A77B-4B589BAFEA66Q40044845-131282B8-B55A-4BBD-B365-D9CE8BB9ABA8Q40123008-D74AA905-02B1-440A-AF16-CB8535AAA39BQ40158192-AC8D9558-BAF1-47B9-A9FA-5700113C7076Q40293980-984E31D6-E885-4713-8282-C0175BD1DFCBQ40451636-05256B2E-F030-460F-B7C5-F7E8228170A8Q40473460-604A45FF-3AFA-429A-A530-7503CEAE2C51Q45146825-C75C1983-823F-49FD-922F-B57F2CFB577FQ46882539-A7B7B756-B1E4-4574-ABA8-F31AEB9E1E70Q50052852-1067CED3-4A05-4418-BFB2-289B58BEA57EQ57233628-E1144EB1-0C80-43A4-AA33-C878309F91E8Q58176266-FCFBE2FB-E23E-4FB3-AD76-7D11B4964887
P2860
Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Functional domain and motif an ...... expression in prostate cancer.
@en
Functional domain and motif an ...... expression in prostate cancer.
@nl
type
label
Functional domain and motif an ...... expression in prostate cancer.
@en
Functional domain and motif an ...... expression in prostate cancer.
@nl
prefLabel
Functional domain and motif an ...... expression in prostate cancer.
@en
Functional domain and motif an ...... expression in prostate cancer.
@nl
P2093
P2860
P356
P1476
Functional domain and motif an ...... expression in prostate cancer.
@en
P2093
Chawnshang Chang
Cheng-Lung Hsu
Erik R Sampson
Eungseok Kim
Huei-Ju Ting
Hui-Kuan Lin
Jiaoti Huang
Liang Wang
P2860
P304
33438-33446
P356
10.1074/JBC.M401781200
P407
P577
2004-05-27T00:00:00Z